Package 0069-3034-20

Brand: doxorubicin hydrochloride

Generic: doxorubicin hydrochloride
NDC Package

Package Facts

Identity

Package NDC 0069-3034-20
Digits Only 0069303420
Product NDC 0069-3034
Description

1 VIAL, MULTI-DOSE in 1 CARTON (0069-3034-20) / 100 mL in 1 VIAL, MULTI-DOSE

Marketing

Marketing Status
Marketed Since 1987-12-23
Brand doxorubicin hydrochloride
Generic doxorubicin hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "1e8e701d-b982-4671-b1ab-38b56826f23f", "openfda": {"unii": ["82F2G7BL4E"], "rxcui": ["1191138", "1790097", "1790099", "1790100"], "spl_set_id": ["1fd148fb-0fbc-4b6f-b790-23546fb46a71"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 CARTON (0069-3034-20)  / 100 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "0069-3034-20", "marketing_start_date": "19871223"}], "brand_name": "Doxorubicin Hydrochloride", "product_id": "0069-3034_1e8e701d-b982-4671-b1ab-38b56826f23f", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Anthracycline Topoisomerase Inhibitor [EPC]", "Anthracyclines [CS]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "0069-3034", "generic_name": "Doxorubicin Hydrochloride", "labeler_name": "Pfizer Laboratories Div Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxorubicin Hydrochloride", "active_ingredients": [{"name": "DOXORUBICIN HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "NDA050629", "marketing_category": "NDA", "marketing_start_date": "19871223", "listing_expiration_date": "20261231"}